Siloam Hospitals | Investor Relations - Financial Statements - Rumah Sakit Siloam Hospitals
PT SILOAM INTERNATIONAL HOSPITALS Tbk
AND SUBSIDIARIES
Interim Consolidated Financial Statements
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
Final Draft/November 25, 2016
Paraf:
PT SILOAM INTERNATIONAL HOSPITALS Tbk
AND SUBSIDIARIES
Table of Contents
Page
Director’s Statement Letter
Interim Consolidated Financial Statements
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
Interim Consolidated Statements of Financial Position
1
Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income
3
Interim Consolidated Statements of Changes in Equity
4
Interim Consolidated Statements of Cash Flows
5
Notes to the Interim Consolidated Financial Statements
6
Draft/November 25, 2016
paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited)
(in Full Rupiah, Unless Otherwise Stated)
ASSETS
Notes
CURRENT ASSETS
Cash and Cash Equivalents
Trade Receivables
Third Parties
Related Parties
Other Current Financial Assets
Inventories
Prepaid Taxes
Prepaid Expenses
Total Current Assets
3, 10, 30, 31
4, 31
10
5, 31
6
7.a
8
NON-CURRENT ASSETS
Advances
Due from Related Parties non-Trade
Property and Equipment
Goodwill
Intangible Assets
Deferred Tax Assets
Other Non-Current Financial Assets
Total Non-Current Assets
TOTAL ASSETS
The accompanying notes form an integral part of these
interim consolidated financial statements
Draft/25 Nopember 2016
9
10, 31
12
13.a
13.b
7.d
11
1
September 30, 2016
Rp
December 31, 2015
Rp
106,047,535,545
159,848,063,872
761,295,332,695
8,630,638,672
13,203,107,268
147,993,426,013
3,524,996,557
105,653,538,255
1,146,348,575,005
565,096,838,752
10,130,038,169
6,457,567,169
140,434,193,057
6,991,423,747
67,134,726,064
956,092,850,830
206,575,481,281
478,245,830
1,619,943,244,585
288,276,804,990
12,158,343,399
28,542,022,387
3,536,160,523
2,159,510,302,995
3,305,858,878,000
150,344,464,185
1,287,224,420
1,553,306,654,744
288,276,804,990
10,704,038,028
22,995,423,430
3,262,687,479
2,030,177,297,276
2,986,270,148,106
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited)
(in Full Rupiah, Unless Otherwise Stated)
LIABILITIES AND EQUITY
Notes
LIABILITIES
CURRENT LIABILITIES
Trade Payables - Third Parties
Short-Term Bank Loans
Accrued Expenses
Advances from Patients
Taxes Payable
Other Current Financial Liabilities
Current Portion of Long-Term Liabilities
Bank Loan
Finance Lease Obligation
Deferred Gain on Sale and LeasebackTransactions
Total Current Liabilities
The accompanying notes form an integral part of these
interim consolidated financial statements
Draft/25 Nopember 2016
254,713,743,081
2,173,564,967
249,661,341,149
10,113,325,361
29,559,388,820
64,186,469,225
17, 31
18, 31
19, 34.a
8,892,868,613
12,190,184,693
11,897,445,548
809,376,961,112
7,482,980,034
-11,897,445,548
629,788,258,185
17, 31
10, 31
18, 31
19, 34.a
20
7.d
11,836,298,355
352,712,458,751
61,035,114,103
98,088,734,291
105,241,881,168
33,491,131,351
662,405,618,019
1,471,782,579,131
23,042,103,703
354,745,657,192
-107,011,818,445
100,057,230,423
31,673,452,294
616,530,262,057
1,246,318,520,242
21
22
115,610,000,000
1,289,664,515,321
(25,748,354,393)
450,280,342,845
1,829,806,503,773
4,269,795,096
1,834,076,298,869
3,305,858,878,000
115,610,000,000
1,289,664,515,321
(25,748,354,393)
364,490,437,227
1,744,016,598,155
(4,064,970,291)
1,739,951,627,864
2,986,270,148,106
7.b
15, 31
EQUITY
Equity Attributable to Owners of the Parent
Capital Stock: par Value Rp100 per Share
Authorized Capital: 4,000,000,000 Shares
Issued and Fully Paid: 1,156,100,000 Shares
Additional Paid-in Capital - Net
Difference in Value from Non-Controlling Interest
Retained Earnings
Total Equity Attributable to owners of the Parent
Non-Controlling Interests
TOTAL EQUITY
TOTAL LIABILITIES AND EQUITY
24
2
December 31, 2015
Rp
297,479,451,928
2,652,465,786
359,199,489,606
19,703,567,680
35,174,520,755
62,186,966,503
14, 31
17, 31
10, 16, 31
NON-CURRENT LIABILITIES
Long-Term Bank Loans
Due to Related Parties Non-Trade
Finance Lease Obligation
Deferred Gain on Sale and Leaseback Transactions
Long-Term employment Benefit Liabilities
Deferred Tax Liabilities
Total Non-Current Liabilities
Total Liabilities
September 30, 2016
Rp
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER
COMPREHENSIVE INCOME
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
(in Full Rupiah, Unless Otherwise Stated)
Notes
2016
(9 Months)
Rp
2015
(9 Months)
Rp
OPERASI YANG DILANJUTKAN
REVENUE
25
3,824,372,630,035
3,013,142,142,653
COST OF REVENUE
26
(2,702,737,456,573)
(2,156,668,016,584)
1,121,635,173,462
856,474,126,069
(908,309,747,596)
(22,093,890,313)
(694,664,909,010)
(20,885,623,267)
191,231,535,553
140,923,593,792
2,068,378,410
(40,976,505,138)
4,040,130,277
(41,922,232,218)
152,323,408,825
103,041,491,850
(57,491,969,129)
(35,436,134,827)
94,831,439,696
67,605,357,023
(942,358,255)
--
235,589,564
(706,768,691)
---
94,124,671,005
67,605,357,023
85,449,838,522
9,381,601,174
94,831,439,696
70,397,573,758
(2,792,216,735)
67,605,357,023
85,789,905,618
8,334,765,387
94,124,671,005
70,397,573,758
(2,792,216,735)
67,605,357,023
73.91
60.89
GROSS PROFIT
Operating Expenses
Others Expenses - Net
10, 27
PROFIT FROM OPERATION
Interest Income
Financial Charges
28
28
PROFIT BEFORE TAX
Tax Expenses
7.c
PROFIT FOR THE PERIOD
OTHER COMPREHENSIVE INCOME
Item that will Not be Reclassified Subsequently to Profit or Loss
Remeasurement of Defined Benefit Plan
Income Tax Related to Item that Will not be
Reclassified to Profit or Loss on Defined Benefit Plan
OTHER COMPREHENSIVE LOSS FOR PERIOD
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD
PROFIT FOR THE PERIOD
ATTRIBUTABLE TO
Owners of the Parent
Non-Controlling Interests
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD
ATTRIBUTABLE TO
Owners of the Parent
Non-Controlling Interests
EARNINGS PER SHARE
Basic, Profit for the Period Attributable to
Ordinary Shareholders of the Parent
The accompanying notes form an integral part of these
interim consolidated financial statements
Draft/25 Nopember 2016
29
3
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
(in Full Rupiah, Unless Otherwise Stated)
Capital Stock
Paid-in Capital
Excess of Par
Notes
BALANCE AS OF DECEMBER 31, 2014
Rp
Rp
Additional Paid-in Capital - Net
Difference in Value
from Transactions Difference in Value
from Change in
between Entities
Under Common Equity Transactions
of Subisdiary
Control - Net
Rp
Rp
Equity Attributable to Owners of the Parent
Difference in Value
from Transaction
Total
with NonControlling Interest
Rp
Rp
Retained Earnings
Appropriated
Unappropriated
Rp
Rp
Other
Comprehensive
Income
Total Equity
Attributable to
Owners of the
Parent
Rp
Rp
Non-Controlling
Interests
Total Equity
Rp
Rp
115,610,000,000
1,312,722,950,000
(11,329,652,726)
(11,728,781,953)
1,289,664,515,321
(25,748,354,393)
23,100,000,000
258,200,384,006
(12,622,920,294)
1,648,203,624,640
5,464,927,320
1,653,668,551,960
----115,610,000,000
----1,312,722,950,000
----(11,329,652,726)
----(11,728,781,953)
----1,289,664,515,321
-(9,683,575,558)
--(35,431,929,951)
----23,100,000,000
(6,011,719,948)
--70,397,573,758
322,586,237,816
----(12,622,920,294)
(6,011,719,948)
(9,683,575,558)
-70,397,573,758
1,702,905,902,892
-(1,686,311,570)
-(2,792,216,735)
986,399,015
(6,011,719,948)
(11,369,887,128)
-67,605,357,023
1,703,892,301,907
BALANCE AS OF DECEMBER 31, 2015
115,610,000,000
1,312,722,950,000
(11,329,652,726)
(11,728,781,953)
1,289,664,515,321
(25,748,354,393)
23,100,000,000
341,390,437,227
--
1,744,016,598,155
(4,064,970,291)
1,739,951,627,864
Changes in Equity for the Period September 30, 2016
Profit for The Period
Other Comprehensive Income for the Period
BALANCE AS OF SEPTEMBER 30, 2016
--115,610,000,000
--1,312,722,950,000
--(11,329,652,726)
--(11,728,781,953)
--1,289,664,515,321
--(25,748,354,393)
--23,100,000,000
85,449,838,522
340,067,096
427,180,342,845
----
85,449,838,522
340,067,096
1,829,806,503,773
9,381,601,174
(1,046,835,787)
4,269,795,096
94,831,439,696
(706,768,691)
1,834,076,298,869
Changes in Equity for the Period September 30, 2015
Cash Dividend
Non-Controlling Interests
Profit for The Period
Other Comprehensive Income for the Period
BALANCE AS OF SEPTEMBER 30, 2015
23
The accompanying notes form an integral part of these
Interim consolidated financial statements
Draft/25 November 2016
4
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
(in Full Rupiah, Unless Otherwise Stated)
Notes
CASH FLOWS FROM OPERATING ACTIVITIES
Cash Receipts from Customers
Payments to Suppliers and Third Parties
Payments to Management and Employees
Cash Flows from Operations
Financial Charges Payment - Net
Payments of Taxes
Net Cash Provided by Operating Activities
CASH FLOWS FROM INVESTING ACTIVITIES
Advances for Purchase of Property and Equipment and Others
Property and Equipment and Software
Disposal
Acquisition
Purchasing of Shares of Subsidiary
Net Cash Used in Investing Activities
12
12, 13.b
CASH FLOWS FROM FINANCING ACTIVITIES
Payment to Related Parties
Payments for Bank Loan
Payments for Obligation Under Finance Lease
Dividend Payment
Net Cash Used in Financing Activities
17
18
NET DECREASE IN CASH AND CASH EQUIVALENTS
Effect of Foreign Exchange on Cash and Cash Equivalents at the End of the Period
2016
(9 Months)
Rp
2015
(9 Months)
Rp
3,651,665,627,139
(2,664,749,824,683)
(637,843,105,673)
349,072,696,783
(4,980,296,491)
(43,447,773,375)
300,644,626,917
2,877,926,235,817
(2,116,830,299,640)
(521,588,602,221)
239,507,333,956
(9,710,189,545)
(17,166,734,547)
212,630,409,864
(44,246,839,040)
(73,541,773,128)
364,234,430
(292,145,067,430)
(2,680,555,548)
(338,708,227,588)
34,084,005
(217,957,674,968)
-(291,465,364,091)
(2,691,021,410)
(9,795,916,769)
(3,579,226,296)
-(16,066,164,475)
(3,500,000,000)
(10,211,400,681)
-(6,011,720,008)
(19,723,120,689)
(54,129,765,147)
(98,558,074,916)
329,236,820
(1,342,032,852)
CASH AND CASH EQUIVALENTS AT BEGINNING PERIOD
3
159,848,063,872
279,958,770,048
CASH AND CASH EQUIVALENTS AT ENDING PERIOD
3
106,047,535,545
180,058,662,280
The accompanying notes form an integral part of these
Interim consolidated financial statements
Draft/25 Nopember 2016
5
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
1. General
1.a. The Company’s Establishment
PT Siloam International Hospitals Tbk. (“the Company”) was established under the name of PT
Sentralindo Wirasta on August 3, 1996 based on the Deed of Establishment No. 3, which was made in
the presence of Myra Yuwono, S.H., a notary in Sukabumi. The deed of establishment was approved
by the Minister of Justice of the Republic of Indonesia in his decree No. C2-8639.HT.01.01.TH.’96. dated
August 27, 1996 and was published in the State Gazette No. 97, Supplement No. 9518 on December 3,
1996.
The Company’s articles of association have been amended several times, and the latest was by Notarial
Deed No. 52 dated March 23, 2016, made in the presence of Sriwi Bawana Nawaksari, S.H., M.Kn., a
notary in Tangerang, to change the Company’s articles of association one of them is the Company’s
purpose and objective. The changes in articles of association was approved by the Minister of Law and
Human Rights of the Republic of Indonesia in his decree No. AHU-AH.01.03-0039805 dated April 11,
2016.
In accordance with Article 3 of the Company's articles of association, the Company's principal activity is
engage in healthcare provision, including setting up and managing hospitals, polyclinics, health facilities
and supporting infrastructure, and engaging in government healthcare programs.
The Company commenced commercial operations in 2010 after the restructuring of PT Lippo Karawaci
Tbk’s hospital units. The Company's principal activity is engage in healthcare provision, including setting
up and managing hospitals. The operation of hospital units of the Company and the subsidiaries (the
Group) are in several cities on the island of Sumatera, Java, Bali, Kalimantan, Sulawesi and Nusa
Tenggara.
The Company’s head office is located at Building of Faculty Medicine UPH, 32th. Floor. Jl. Boulevard
Jend. Sudirman No.15, Tangerang 15810, Banten - Indonesia. The parent entity of the Company is PT
Megapratama Karya Persada and the ultimate parent entity is PT Lippo Karawaci Tbk.
1.b. The Company’s Initial Public Offering
The Company’s initial public offering of 156,100,000 shares was declared effective by the Indonesian
Financial Services Authority in its letter No. S-260/D.04/2013 dated September 2, 2013, and was listed
in the Indonesian Stock Exchange on September 12, 2013.
1.c. The Group’s Structure
The Company has directly or indirectly more than 50% ownership in subsidiaries as follows:
Final Draft/November 24, 2016
6
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
Domicile
Main
Business
Direct
Ownership
Percentage
Indirect
Ownership
Percentage
Year
Starting
Operation
PT Aritasindo Permaisemesta
Jakarta
Trading,
Development,
Mining,
Agriculture,
Land Transpotation,
Printing and
Industry
99.99%
--
--
64,124,071
76,559,368
PT Perdana Kencana Mandiri
Jakarta
Industry,
Development,
Trading,
Land Transpotation,
Workshop,
Printing,
Agriculture,
Mining and
Services
99.75%
--
--
519,803,207
600,000
Tangerang
Development,
Trading
and Services
Healthcare
Trading,
Development,
Land Transportation,
and Services
99.99%
--
--
446,884,661
9,138,115
-99.99%
59.69%
--
---
961,248,650
101,895,978,125
932,687,770
119,221,333,904
Healthcare
Development
and Services
Healthcare and
Pharmacy
Trading,
Development,
Industry,
Mining,
Land Transportation,
Agriculture,
Printing,
Workshop and
Services except
Services of Legal
and Tax
-99.97%
79.84%
--
2002
--
101,881,819,612
78,357,259,109
119,214,480,391
80,468,088,384
--
83.00%
2008
78,356,125,591
80,465,849,866
99.98%
--
--
208,547,878,543
227,620,609,168
Healthcare
including
Hospital,
Clinic,
Health Centre,
Polyclinic and
Other related
Services
Healthcare
Trading,
Industry
and Services
--
79.71%
2007
169,371,985,039
188,450,190,279
99.99%
99.99%
---
2013
2013
1,018,115,487
1,402,502,121
2,611,998,278
3,469,450,033
PT Multiselaras Anugerah
PT Nusa Medika Perkasa
PT Siloam Graha Utama and Subsidiary
Jakarta
Jakarta
PT East Jakarta Medika
PT Guchi Kencana Emas and Subsidiary
Bekasi
Jakarta
PT Golden First Atlanta
PT Prawira Tata Semesta and Subsidiary
PT Balikpapan Damai Husada
Jambi
Jakarta
Balikpapan
PT Siloam Emergency Services
PT Medika Harapan Cemerlang Indonesia
Tangerang
Tangerang
PT Pancawarna Semesta and Subsidiary
Tangerang
Trading,
Development,
Printing
and Services
99.99%
--
--
64,360,037,857
67,236,534,472
Depok
Hospital services
Clinic and
Policlinic,
Medical
Treatment Clinic
and
Other related
Services
Trading,
Development,
Printing
and Services
Trading,
Development,
Printing
and Services
Trading,
Development,
Printing
and Services
--
80.00%
2006
33,818,143,091
36,679,652,912
99.90%
--
--
1,205,502,721
1,012,776,138
99.99%
--
--
594,553,333
594,998,333
99.99%
--
--
594,220,000
594,665,000
PT Diagram Healthcare Indonesia
PT Adamanisa Karya Sejahtera
Jakarta
PT Brenada Karya Bangsa
Tangerang
PT Harmoni Selaras Indah
Tangerang
Final Draft/November 24, 2016
7
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
PT Kusuma Primadana and Subsidiary
PT Adijaya Buana Sakti and Subsidiary
Domicile
Main
Business
Tangerang
Trading,
Development,
Printing and
Healthcare including
Services,
Clinic and
Policlinic,
Medical Treatment
Clinic and Other
related Services
Services,
Development,
Trading,
Workshop,
Land Transportation,
Printing
and Agriculture
Trading,
Development
and Services
Healthcare include
Hospital
Clinic and
Health Center,
Polyclinic and
Other Related
Service
Services,
Development,
Trading,
Workshop,
Land Transportation
Industry,
Printing
and Agriculture
Trading,
Development,
Printing
and Services
Trading,
Development,
Printing
and Services
Tangerang
PT Siloam Sumsel Kemitraan
Tangerang
PT RS Siloam Hospital Sumsel
(d/h PT Karyatama Indah Sentosa)
Palembang
PT Optimum Karya Persada
Jakarta
PT Rosela Indah Cipta
Tangerang
PT Sembada Karya Megah
Tangerang
PT Trijaya Makmur Bersama
Tangerang
PT Visindo Galaxi Jaya
Tangerang
PT Tunggal Pilar Perkasa and Subsidiary
Tangerang
PT Tirtasari Kencana
Serang
PT Gramari Prima Nusa
Medan
PT Krisolis Jaya Mandiri
Kupang
PT Kusuma Bhakti Anugerah
Ambon
Final Draft/November 24, 2016
Trading,
Development,
Printing
and Services
Trading,
Development,
Real Estate,
Industry,
Printing,
Agribusiness
Services
and Transport
Trading,
Development,
Printing and
Services
Healthcare Services
including Hospitals,
Clinic,
Health Center
and Other
Related Service
Direct
Ownership
Percentage
99.99%
Indirect
Ownership
Percentage
--
Year
Starting
Operation
--
--
80.00%
--
86,671,405,047
144,275,110,897
--
56.00%
--
8,000,678,670
7,991,123,670
--
70.00%
2012
86,669,876,099
145,272,691,949
99.90%
--
--
1,000,525,300
1,000,970,300
99.99%
--
--
594,220,000
594,665,000
99.99%
--
--
602,221,157
602,666,157
99.99%
--
--
594,220,000
594,665,000
99.99%
--
--
4,984,503,333
4,984,948,333
99.99%
--
--
1,320,272,761,336
1,104,842,861,746
--
99.99%
--
1,146,614,218
1,129,177,218
--
99.99%
2014
132,536,312,953
142,285,912,947
--
99.99%
2014
189,757,104,377
135,816,231,542
--
99.99%
--
7,185,911,032
7,186,262,922
Healthcare and
Hospitals
Healthcare Services
including Hospitals,
Clinic,
Health Center
and Other
Related Service
Healthcare Services
Hospitals Clinic,
Health Center,
and Other
Related Service
8
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
86,672,025,047
144,276,175,897
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
PT Agung Cipta Raya
PT Bina Cipta Semesta
PT Mega Buana Bhakti
PT Taruna Perkasa Megah
PT Tataka Bumi Karya
PT Tataka Karya Indah
PT Siloam Medika Cemerlang
PT Koridor Usaha Maju and Subsidiary
PT Medika Sarana Traliansia and Subsidiary
PT Trisaka Reksa Waluya
PT Buana Utama Sejati
PT Sentra Sejahtera Utama
PT Bumi Unggul Persada*)
PT Berlian Cahaya Indah
Final Draft/November 24, 2016
Domicile
Semarang
Main
Business
Healthcare Services
including Hospitals,
Clinic,
and Other
Related Service
Padang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Bangka
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Yogya
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Bogor
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
Bandung
including Hospitals,
Clinic, Health Center
and Other
Related Service
Tangerang
Trading, Development,
Real Estate, Industry, Printing,
Agribusiness and Services
Tangerang
Trading,
Development,
Printing,
Agribusiness,
Services
Badung, Bali
Hospital
Public
Services
Badung
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Sorong
Hospital Service
Clinic, Policlinic
and Treatment
Clinic
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Direct
Ownership
Percentage
--
Indirect
Ownership
Percentage
99.99%
Year
Starting
Operation
--
--
99.99%
--
998,453,474
998,898,474
--
99.99%
--
7,991,308,336
6,289,590,225
--
99.99%
--
108,622,860,704
96,121,791,102
--
99.99%
--
22,140,591,003
845,251,870
--
99.99%
--
853,775,252
825,433,327
--
99.99%
2013
14,539,528,553
12,240,837,850
--
99.99%
--
504,494,600,950
480,847,930,537
--
99.99%
2008
291,390,763,441
266,476,908,793
--
99.99%
2008
136,045,604,756
137,390,081,888
--
99.99%
--
23,372,794,731
23,370,843,650
--
99.99%
--
600,000,000
600,000,000
--
99.99%
--
644,452,981
641,265,124
--
99.99%
2014
77,234,430,162
138,001,094,698
9
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
965,780,000
964,225,000
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
Domicile
Main
Business
PT Rashal Siar Cakra Medika
Jakarta
PT Mulia Pratama Cemerlang
Tangerang
PT Medika Rescue International
d/h formerly PT Karya Pesona Cemerlang
PT Indah Kemilau Abadi
Tangerang
PT Persada Dunia Semesta
Tangerang
PT Inti Pratama Medika
Tangerang
PT Sentra Sehat Sejahtera
Tangerang
PT Genta Raya Internusa
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Trading and
Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Jember
PT Sembilan Raksa Dinamika
Jakarta
PT Saritama Mandiri Zamrud
Jakarta
PT Gempita Nusa Sejahtera
Jakarta
PT Aryamedika Teguh Tunggal
Jakarta
PT Lintas Buana Jaya*)
Nusa Tenggara
Timur
PT Bina Bahtera Sejati*)
Baubau
Final Draft/November 24, 2016
Direct
Ownership
Percentage
--
Indirect
Ownership
Percentage
99.99%
Year
Starting
Operation
2008
--
99.99%
--
39,865,743,567
3,679,309,300
--
99.99%
--
3,267,915,053
878,649,715
--
99.99%
--
2,495,803,040
657,128,900
--
99.99%
--
10,465,750,452
2,349,333,094
--
99.99%
--
610,877,342
600,363,000
--
99.99%
--
2,072,408,873
878,649,715
--
99.99%
--
612,945,508
600,388,000
--
99.99%
2016
147,357,646,767
54,795,114,119
--
99.99%
--
600,000,000
600,000,000
--
99.99%
--
600,000,000
600,000,000
--
99.99%
--
600,000,000
600,000,000
--
99.99%
2016
45,194,122,437
9,886,018,026
--
99.99%
2016
42,511,870,096
600,000,000
10
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
75,806,642,408
59,415,242,800
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
Domicile
Main
Business
PT Lintang Laksana Utama*)
Kota Lubuk
Linggau
PT Ciptakarya Tirta Cemerlang*)
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Trading,
Development
Printing,
Service
PT Mahkota Buana Selaras
Tangerang
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
600,000,000
600,000,000
Direct
Ownership
Percentage
--
Indirect
Ownership
Percentage
99.99%
Year
Starting
Operation
--
--
99.99%
--
600,000,000
600,000,000
99.99%
--
--
35,695,009,846
37,690,051,627
*) Established on 2015
1.d. Board of Commissioners, Directors, Employees and Audit Committee
Based on Notarial Deed No. 52 dated March 23, 2016, made in the presence of Sriwi Bawana
Nawaksari, S.H., M.Kn., Notary in Tangerang, which has been accepted by the Ministry of
Law and Human Rights of the Republic of Indonesia through notification No. AHU-AH.01.030039805 dated April 11, 2016, based on Notarial Deed No. 9 dated June 12, 2015, made in
the presence of Nurlani Yusup, S.H., M.Kn., notary in Tangerang, which has been accepted
by the Ministry of Law and Human Rights of the Republic of Indonesia through notification No.
AHU-AH.01.03-0942314 dated June 17, 2015 and based on Notarial Deed No. 1 dated May
2, 2014, made in the presence of Nurlani Yusup, S.H., M.Kn., Notary in Jakarta, which has
been accepted by Ministry of Law and Human Rights of the Republic of Indonesia through
notification No. AHU-06412.40.22.2014 dated May 5, 2014, the composition of the Board of
Commisioners and Directors as of June 30, 2016, December 31, 2015, 2014 and 2013, are
as follows:
Board of Commissioners
President Commissioner
Commissioner
Independent Commissioner
Final Draft/November 24, 2016
September 30, 2016
December 31, 2015
Lee Heok Seng
Theo Leo Sambuaga
Jenny Kuistono
-Farid Harianto
Dr. Niel Byron Nielson
Jonathan Limbong Parapak
Ketut Budi Wijaya
Theo Leo Sambuaga
Jenny Kuistono
Lambock V. Nahattands
Farid Harianto
Dr. Niel Byron Nielson
Jonathan Limbong Parapak
11
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
September 30, 2016
Directors
President Director
Director
Romeo Fernandez Lledo *)
Grace Frelita Indradjaja
Andry
Kailas N. Raina
Anang Prayudi
Prof. George Matthew
Budi Raharjo Legowo
Norita Alex
Caroline Riady
December 31, 2015
Romeo Fernandez Lledo *)
Grace Frelita Indradjaja
Andry
Kailas N. Raina
Anang Prayudi
Prof. George Matthew
Richard Hendro Setiadi WP
---
*) Independent Director
The audit committee composition as of September 30, 2016 and December 31, 2015 are as follows:
Audit Committee
Chairman
: Farid Harianto
Members
: Lim Kwang Tak
: Siswanto Pramono
As of September 30, 2016 and December 31, 2015, the Company’s Corporate Secretary is Cindy
Riswantyo. Head of internal audit is Gunawan HP.
As of September 30, 2016 and December 31, 2015, the Group have 7,643 and 6,974 permanent
employees, respectively (unaudited).
2. Summary of Significant Accounting Policies
2.a. Compliance with the Financial Accounting Standards
The interim consolidated financial statements were prepared and presented in accordance with
Indonesian Financial Accounting Standards which include the Statement of Financial Accounting
Standards (PSAK) and Interpretation of Financial Accounting Standards (ISAK) issued by the Financial
Accounting Standard Board – Indonesian Institute of Accountant (DSAK – IAI), and regulations in the
Capital Market include Regulations of Financial Sevices Authority/Capital Market and Supervisory Board
and Financial Institution (OJK/Bapepam-LK) No. VIII.G.7 regarding guidelines for the presentation of
financial statements, decree of Chairman of Bapepam-LK No. KEP-347/BL/2012 regarding presentation
and disclosure of financial statements of the issuer or public company.
2.b. Basis of Measurement and Preparation of Interim Consolidated Financial Statements
The interim consolidated financial statements have been prepared and presented based on going
concern assumption and accrual basis of accounting, except for the consolidated statements of cash
flows. Basis of measurement in preparation of these interim consolidated financial statements is the
historical costs concept, except for certain accounts which have been prepared on the basis of other
measurements as described in their respective policies. Historical cost is generally based on the fair
value of the consideration given in exchange for assets.
The interim consolidated statements of cash flows are prepared using the direct method by classifying
cash flows into operating, investing and financing activities.
Final Draft/November 24, 2016
12
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
The presentation currency used in the preparation of the interim consolidated financial statements is
Indonesian Rupiah which is the functional currency of the Group. Each entity in the Group determines
its own functional currency and items included in the financial statements of each entity are measured
using that functional currency.
2.c. New and Revised Statements and Interpretation of Financial Accounting
Standards Effective in the Current Year
The following are revision, amendments and adjustments of standards and interpretation of standard
issued by DSAK - IAI and effectively applied for the year starting on or after January 1, 2016, are as
follows:
Amendments
SFAS No. 4: “Separate Financial Statements”
SFAS No.15: “Investment in Associates and Joint Arrangements”
SFAS No.16 ”Property and equipment about Clarification of Acceptable Methods of Depreciation and
Amortization”,
SFAS No.19 ”Intangible Asset about Clarification of Acceptable Methods of Depreciation and
Amortization”,
SFAS No. 24: “Employee Benefits”
SFAS No. 65: “Consolidation Financial Statements”
SFAS No. 66: “Joint Arrangements”
SFAS No. 67: “Disclosures of Interest in Other Entities”
Adjustments
SFAS No. 5: “Operating Segments”
SFAS No. 7: “Related Party Disclosures”
SFAS No. 13: “Investments Property”
SFAS No. 16: “Property and Equipment”
SFAS No. 19: “Intangible Assets”
SFAS No. 22: “Business Combination”
SFAS No. 25: “Accounting Policies, Changes in Accounting Estimates and Errors”
SFAS No. 53: “Share-based Payments”
SFAS No. 68: “Fair Value Measurement”
The following is the impact of the revision, amendments and adjustments in accounting standards that
are relevant and significant to the interim consolidated financial statements of the Group among others:
SFAS No. 5 (Adjustment 2015): “Operating Segments”
The impact of the adjustment of this standard include:
a. Additional disclosure requirements of establishing the criteria for the combine of the operating
segments and the brief description of the operating segments have been combined and the
assessed economic indicators in determining of the combined operating segments have similar
economic characteristics,
b. Organize disclosures of the reconciliation of the reportable total assets segments to the entity’s
assets only if the assets segment are regularly provided to the chief operating decision maker,
and
c. Changes previous terminology is "reportable segments of the entity" to "the entity’s reportable
segments "and "based on differences in products and services" to "based on products and
services".
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statements.
Final Draft/November 24, 2016
13
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
SFAS No. 7 (Adjustment 2015): “Related Party Disclosures”
The impact of adjustment of this standard include:
a. Addition of requirements related parties, An entity is related to the reporting entity if entity or
members of the same group which that entity is related to others, provide member of the key
management personnel of the reporting entity or of a parent of the reporting entity.
b. Requiring that a reporting entity disclose the payment of key management personnel services
provided by the entity management and clarifies that the reporting entity is not required to disclose
the compensation paid of the entity management to its employees or Director, and
c. Changing the terminology of "the effective date" to be "effective date and transitional
requirement".
The Group had adopted the adjustment standard and had completed the requested requirements.
SFAS No. 13 (Adjustment 2015): “Investments Property”
Adjustment to this standard emphasize the difference between investment property and owneroccupied property and emphasize the need for consideration on the determination of whether the
acquisition of the investment property is classified as an asset acquisition or a business combination
within the scope of SFAS No. 22.
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 15 (Amendment 2015): “Investment in Associates and Joint Arrangements”
Adjustment to this standard, add that an entity which is not an investment entity having an interest in
investment entity and joint venture that is investment entity, then when applying the equity method
can maintain the fair value measurement that applied by the investment entity an associate or joint
venture in subsidiary where the investment entity an associate or joint venture are concerned.
The adoption of the amendment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 16 (Adjustment 2015): “Property and equipment”
Adjustment of this standard, add an explanation that:
a. The reduction is expected to occur in the future on the selling price of goods produced using an
property and equipment indicates presumption of the technical or commercial obsolescence of
the assets, and
b. Depreciation method based on the income generated by activities that use an asset is not
appropriate.
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 19 (Adjustment 2015): “Intangible Assets”
The Impact of the adjustments of this standard includes:
a. Provide additional explanation that the reduction is expected to occur in the future on the selling
price of goods produced using an intangible asset indicates presumption of the technical or
commercial obsolescence of the assets,
b. There is a presumption that the use of methods of amortization based on the revenues generated
by activities using the intangible assets allegedly not appropriate because it reflects factors that
are not directly related to the use of economic benefits contained in the intangible assets,
c. Basic selection the amortization of intangible assets is if its reflect the pattern of the estimated
economic benefits of the asset, and
Final Draft/November 24, 2016
14
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
d. In circumstances where the dominant inherent barrier factor in an intangible asset is the
achievement of revenue threshold, then the revenue generated can be used as a proper basis
for amortization.
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 22 (Adjustment 2015): “Business Combination”
The adjustments of this standard is added the explanation that:
a. SFAS No. 22 is not applied in accounting for the forming of a joint arrangement in the financial
statements of joint arrangement it self,
b. The obligation to pay contingent consideration that meet the definition of financial instruments
classified as financial liabilities or as equity, and
c. The entire contingent consideration which is not an equity, both financial and non-financial are
measured at fair value at each reporting date, with the changes in fair value are recognized in
profit or loss.
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statement.
SFAS No. 24 (Amendment 2015): “Employee Benefits”
The amendment to this standard specifies that attribution dues from workers or third parties depend
on whether the contribution rate is set based on the number of year of services. If the dues based on
the number of year services, then the dues attributable to the period of services using the same
method with attribution required. If the amount of contributions does not depend on the number of year
of services then the contribution is recognized as a reduction of the cost of services in the period when
the related services provided by workers.
The adoption of the amendment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 25 (Adjustment 2015): “Accounting Policies, Changes in Accounting Estimates and Errors”
Change in SFAS No. 25 (Adjustment 2015), mainly to incorporate the changes of editorial in the
previous standard.
The adoption of the adjustment of the standard had no material effect to the interim consolidated
financial statements.
SFAS No. 65 “Consolidated Financial Statements”
This standard replaces all of the guidance on control and consolidation in SFAS No. 4 (Revised 2009)
and ISAK No.7. The basic principle that a consolidated entity presents a parent and its subsidiaries
as if they are a single economic entity remains unchanged, as do the consolidation procedures.
PSAK 65 introduces a single consolidation model that identifies control as the basis for consolidation
for all types of entities, where control is based on whether an investor has power over the investee,
exposure / rights to variable returns from its involvement with the investee and the ability to use its
power over the investee to affect the amount of the returns.
The new standard also includes guidance on participating and protective rights and on agent principal relationships.
The adoption of the SFAS No. 65 has no impact to the interim consolidated financial statements upon
Final Draft/November 24, 2016
15
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
initial adoption, as its scope of consolidation remains unchanged.
SFAS No. 66 “Joint Arrangements”
PSAK No. 66 has purpose to establish principles for financial reporting entity that have interests in
jointly controlled scheme ( ie joint arrangements ). This statement is applied by all entities that are
parties to the joint arrangement .
SFAS No. 67 “Disclosure of Interests in Other Entities”
SFAS No. 67 combines, enhances, and replaces the disclosure requirements for subsidiaries, joint
arrangements, associates, and unconsolidated structured entities. This standard requires the Group
to disclose information that enables users of financial statements to evaluate the nature of, and risks
associated with, its interests in other entities and the effects of those interests on Group’s
consolidated financial statements.
The application of this standard has resulted in more extensive disclosures in the Group’s interim
consolidated financial statements.
SFAS No. 68 “Fair Value Measurement”
SFAS No. 68 defines fair value, sets out a single framework for measuring fair value and requires
disclosures about fair value measurements. SFAS No.68 applies when other SAKs require or permit
fair value measurements.
The Group has completed the disclosures requirement as required under this standard.
2.d. Principles of Consolidation
The interim consolidated financial statements incorporate the financial statements of the Company and
subsidiaries as described in Note 1.c.
A subsidiary is an entity controlled by the Group, the Group is exposed, or has rights, to variable returns
from its involvement with the entity and has the ability to affect those returns through its current ability
to direct the entity’s relevant activities (power over the investee).
The existence and effect of substantive potential voting rights that the Group has the practical ability to
exercise (i.e., substantive rights) are considered when assessing whether the Group controls another
entity.
The Group’s of interim consolidated financial statements incorporate the business results, cash flows,
assets and liabilities of the Company and all of its directly and indirectly controlled subsidiaries.
Subsidiaries are consolidated from the effective date of acquisition, which is the date on which the Group
effectively obtains control of the acquired business, until that control ceases.
Parent company prepares interim consolidated financial statements applying uniform accounting
policies for like transactions and other events in similar circumstances. All intragroup transactions,
balances, income, expenses and cash flows are eliminated in full on consolidation to reflect the financial
position of a single business entity.
The Group attributed the profit and loss and each component of other comprehensive income to the
owners of the parent and non-controlling interest even though this results in the non-controlling interests
having a deficit balance. The Group presents non-controlling interest in equity in the interim consolidated
statement of financial position, separately from the equity owners of the parent.
Final Draft/November 24, 2016
16
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Changes in the parent’s ownership interest in a subsidiary that do not result in loss of control are equity
transactions (i.e., transactions with owners in their capacity as owners). When the proportion of equity
held by non-controlling interest change, the Group adjusted the carrying amounts of the controlling
interest and non-controlling interest to reflect the changes in their relative interest in the subsidiaries.
Any difference between the amount by which the non-controlling interests are adjusted and the fair value
of the consideration paid or received is recognized directly in equity and attributed to the owners of the
parent.
If the Group loses control, the Group:
(a) Derecognizes the assets (including goodwill) and liabilities of the subsidiary at their carrying
amounts at the date when control is lost;
(b) Derecognizes the carrying amount of any non-controlling interests in the former subsidiary at the
date when control is lost (including any components of other comprehensive income attributable
to them);
(c) Recognizes the fair value of the consideration received, if any, from the transaction, event or
circumstances that resulted in the loss of control;
(d) Recognizes any investment retained in the former subsidiary at fair value at the date when control
is lost;
(e) Reclassifies to profit or loss, or transfer directly to retained earnings if required by other
Accounting Standards, the amount recognized in other comprehensive income in relation to the
subsidiary;
(f)
Recognizes any resulting difference as a gain or loss attributable to the parent.
2.e. Foreign Currency Transactions and Balances
In preparing interim financial statements, each of the entity within the Group records by using the
currency of the primary economic environment in which the entity operates (“the functional currency”).
The functional currency of the Company and all of the subsidiaries is Rupiah.
Transactions during the period in foreign currencies are recorded in Rupiah by applying to the foreign
currency amount the spot exchange rate between Rupiah and the foreign currency at the date of
transactions. At the end of reporting period, foreign currency monetary items are translated to Rupiah
using the closing rate, i.e., middle rate of Bank of Indonesia as of September 30, 2016 and December
31, 2015 are as follows:
September 30, 2016 December 31, 2015
Rp
Rp
12,998
13,795
14,579
15,069
9,522
9,751
9,912
10,064
1 Dolar Amerika Serikat (USD)
1 Euro (EUR)
1 Dolar Singapura (SGD)
1 Dolar Australia (AUD)
Gains and losses from foreign exchange differences arising from foreign currency transactions are
recoqnized in profit or loss.
2.f. Cash and Cash Equivalent
Cash and cash equivalents are cash on hand, cash in banks (demand deposits) and time deposits with
maturity periods of three months or less at the time of placement that are not used as collateral or are
not restricted.
2.g. Related Parties Transactions and Balances
A related party is a person or an entity that is related to the reporting entity:
Final Draft/November 24, 2016
17
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
(a) A person or a close member of that person’s family is related to a reporting entity if that person:
(i) has control or joint control over the reporting entity;
(ii) has significant inf
AND SUBSIDIARIES
Interim Consolidated Financial Statements
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
Final Draft/November 25, 2016
Paraf:
PT SILOAM INTERNATIONAL HOSPITALS Tbk
AND SUBSIDIARIES
Table of Contents
Page
Director’s Statement Letter
Interim Consolidated Financial Statements
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
Interim Consolidated Statements of Financial Position
1
Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income
3
Interim Consolidated Statements of Changes in Equity
4
Interim Consolidated Statements of Cash Flows
5
Notes to the Interim Consolidated Financial Statements
6
Draft/November 25, 2016
paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited)
(in Full Rupiah, Unless Otherwise Stated)
ASSETS
Notes
CURRENT ASSETS
Cash and Cash Equivalents
Trade Receivables
Third Parties
Related Parties
Other Current Financial Assets
Inventories
Prepaid Taxes
Prepaid Expenses
Total Current Assets
3, 10, 30, 31
4, 31
10
5, 31
6
7.a
8
NON-CURRENT ASSETS
Advances
Due from Related Parties non-Trade
Property and Equipment
Goodwill
Intangible Assets
Deferred Tax Assets
Other Non-Current Financial Assets
Total Non-Current Assets
TOTAL ASSETS
The accompanying notes form an integral part of these
interim consolidated financial statements
Draft/25 Nopember 2016
9
10, 31
12
13.a
13.b
7.d
11
1
September 30, 2016
Rp
December 31, 2015
Rp
106,047,535,545
159,848,063,872
761,295,332,695
8,630,638,672
13,203,107,268
147,993,426,013
3,524,996,557
105,653,538,255
1,146,348,575,005
565,096,838,752
10,130,038,169
6,457,567,169
140,434,193,057
6,991,423,747
67,134,726,064
956,092,850,830
206,575,481,281
478,245,830
1,619,943,244,585
288,276,804,990
12,158,343,399
28,542,022,387
3,536,160,523
2,159,510,302,995
3,305,858,878,000
150,344,464,185
1,287,224,420
1,553,306,654,744
288,276,804,990
10,704,038,028
22,995,423,430
3,262,687,479
2,030,177,297,276
2,986,270,148,106
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited)
(in Full Rupiah, Unless Otherwise Stated)
LIABILITIES AND EQUITY
Notes
LIABILITIES
CURRENT LIABILITIES
Trade Payables - Third Parties
Short-Term Bank Loans
Accrued Expenses
Advances from Patients
Taxes Payable
Other Current Financial Liabilities
Current Portion of Long-Term Liabilities
Bank Loan
Finance Lease Obligation
Deferred Gain on Sale and LeasebackTransactions
Total Current Liabilities
The accompanying notes form an integral part of these
interim consolidated financial statements
Draft/25 Nopember 2016
254,713,743,081
2,173,564,967
249,661,341,149
10,113,325,361
29,559,388,820
64,186,469,225
17, 31
18, 31
19, 34.a
8,892,868,613
12,190,184,693
11,897,445,548
809,376,961,112
7,482,980,034
-11,897,445,548
629,788,258,185
17, 31
10, 31
18, 31
19, 34.a
20
7.d
11,836,298,355
352,712,458,751
61,035,114,103
98,088,734,291
105,241,881,168
33,491,131,351
662,405,618,019
1,471,782,579,131
23,042,103,703
354,745,657,192
-107,011,818,445
100,057,230,423
31,673,452,294
616,530,262,057
1,246,318,520,242
21
22
115,610,000,000
1,289,664,515,321
(25,748,354,393)
450,280,342,845
1,829,806,503,773
4,269,795,096
1,834,076,298,869
3,305,858,878,000
115,610,000,000
1,289,664,515,321
(25,748,354,393)
364,490,437,227
1,744,016,598,155
(4,064,970,291)
1,739,951,627,864
2,986,270,148,106
7.b
15, 31
EQUITY
Equity Attributable to Owners of the Parent
Capital Stock: par Value Rp100 per Share
Authorized Capital: 4,000,000,000 Shares
Issued and Fully Paid: 1,156,100,000 Shares
Additional Paid-in Capital - Net
Difference in Value from Non-Controlling Interest
Retained Earnings
Total Equity Attributable to owners of the Parent
Non-Controlling Interests
TOTAL EQUITY
TOTAL LIABILITIES AND EQUITY
24
2
December 31, 2015
Rp
297,479,451,928
2,652,465,786
359,199,489,606
19,703,567,680
35,174,520,755
62,186,966,503
14, 31
17, 31
10, 16, 31
NON-CURRENT LIABILITIES
Long-Term Bank Loans
Due to Related Parties Non-Trade
Finance Lease Obligation
Deferred Gain on Sale and Leaseback Transactions
Long-Term employment Benefit Liabilities
Deferred Tax Liabilities
Total Non-Current Liabilities
Total Liabilities
September 30, 2016
Rp
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER
COMPREHENSIVE INCOME
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
(in Full Rupiah, Unless Otherwise Stated)
Notes
2016
(9 Months)
Rp
2015
(9 Months)
Rp
OPERASI YANG DILANJUTKAN
REVENUE
25
3,824,372,630,035
3,013,142,142,653
COST OF REVENUE
26
(2,702,737,456,573)
(2,156,668,016,584)
1,121,635,173,462
856,474,126,069
(908,309,747,596)
(22,093,890,313)
(694,664,909,010)
(20,885,623,267)
191,231,535,553
140,923,593,792
2,068,378,410
(40,976,505,138)
4,040,130,277
(41,922,232,218)
152,323,408,825
103,041,491,850
(57,491,969,129)
(35,436,134,827)
94,831,439,696
67,605,357,023
(942,358,255)
--
235,589,564
(706,768,691)
---
94,124,671,005
67,605,357,023
85,449,838,522
9,381,601,174
94,831,439,696
70,397,573,758
(2,792,216,735)
67,605,357,023
85,789,905,618
8,334,765,387
94,124,671,005
70,397,573,758
(2,792,216,735)
67,605,357,023
73.91
60.89
GROSS PROFIT
Operating Expenses
Others Expenses - Net
10, 27
PROFIT FROM OPERATION
Interest Income
Financial Charges
28
28
PROFIT BEFORE TAX
Tax Expenses
7.c
PROFIT FOR THE PERIOD
OTHER COMPREHENSIVE INCOME
Item that will Not be Reclassified Subsequently to Profit or Loss
Remeasurement of Defined Benefit Plan
Income Tax Related to Item that Will not be
Reclassified to Profit or Loss on Defined Benefit Plan
OTHER COMPREHENSIVE LOSS FOR PERIOD
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD
PROFIT FOR THE PERIOD
ATTRIBUTABLE TO
Owners of the Parent
Non-Controlling Interests
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD
ATTRIBUTABLE TO
Owners of the Parent
Non-Controlling Interests
EARNINGS PER SHARE
Basic, Profit for the Period Attributable to
Ordinary Shareholders of the Parent
The accompanying notes form an integral part of these
interim consolidated financial statements
Draft/25 Nopember 2016
29
3
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
(in Full Rupiah, Unless Otherwise Stated)
Capital Stock
Paid-in Capital
Excess of Par
Notes
BALANCE AS OF DECEMBER 31, 2014
Rp
Rp
Additional Paid-in Capital - Net
Difference in Value
from Transactions Difference in Value
from Change in
between Entities
Under Common Equity Transactions
of Subisdiary
Control - Net
Rp
Rp
Equity Attributable to Owners of the Parent
Difference in Value
from Transaction
Total
with NonControlling Interest
Rp
Rp
Retained Earnings
Appropriated
Unappropriated
Rp
Rp
Other
Comprehensive
Income
Total Equity
Attributable to
Owners of the
Parent
Rp
Rp
Non-Controlling
Interests
Total Equity
Rp
Rp
115,610,000,000
1,312,722,950,000
(11,329,652,726)
(11,728,781,953)
1,289,664,515,321
(25,748,354,393)
23,100,000,000
258,200,384,006
(12,622,920,294)
1,648,203,624,640
5,464,927,320
1,653,668,551,960
----115,610,000,000
----1,312,722,950,000
----(11,329,652,726)
----(11,728,781,953)
----1,289,664,515,321
-(9,683,575,558)
--(35,431,929,951)
----23,100,000,000
(6,011,719,948)
--70,397,573,758
322,586,237,816
----(12,622,920,294)
(6,011,719,948)
(9,683,575,558)
-70,397,573,758
1,702,905,902,892
-(1,686,311,570)
-(2,792,216,735)
986,399,015
(6,011,719,948)
(11,369,887,128)
-67,605,357,023
1,703,892,301,907
BALANCE AS OF DECEMBER 31, 2015
115,610,000,000
1,312,722,950,000
(11,329,652,726)
(11,728,781,953)
1,289,664,515,321
(25,748,354,393)
23,100,000,000
341,390,437,227
--
1,744,016,598,155
(4,064,970,291)
1,739,951,627,864
Changes in Equity for the Period September 30, 2016
Profit for The Period
Other Comprehensive Income for the Period
BALANCE AS OF SEPTEMBER 30, 2016
--115,610,000,000
--1,312,722,950,000
--(11,329,652,726)
--(11,728,781,953)
--1,289,664,515,321
--(25,748,354,393)
--23,100,000,000
85,449,838,522
340,067,096
427,180,342,845
----
85,449,838,522
340,067,096
1,829,806,503,773
9,381,601,174
(1,046,835,787)
4,269,795,096
94,831,439,696
(706,768,691)
1,834,076,298,869
Changes in Equity for the Period September 30, 2015
Cash Dividend
Non-Controlling Interests
Profit for The Period
Other Comprehensive Income for the Period
BALANCE AS OF SEPTEMBER 30, 2015
23
The accompanying notes form an integral part of these
Interim consolidated financial statements
Draft/25 November 2016
4
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
For the 9 (Nine) Months Periods Ended September 30, 2016 and 2015 (Unaudited)
(in Full Rupiah, Unless Otherwise Stated)
Notes
CASH FLOWS FROM OPERATING ACTIVITIES
Cash Receipts from Customers
Payments to Suppliers and Third Parties
Payments to Management and Employees
Cash Flows from Operations
Financial Charges Payment - Net
Payments of Taxes
Net Cash Provided by Operating Activities
CASH FLOWS FROM INVESTING ACTIVITIES
Advances for Purchase of Property and Equipment and Others
Property and Equipment and Software
Disposal
Acquisition
Purchasing of Shares of Subsidiary
Net Cash Used in Investing Activities
12
12, 13.b
CASH FLOWS FROM FINANCING ACTIVITIES
Payment to Related Parties
Payments for Bank Loan
Payments for Obligation Under Finance Lease
Dividend Payment
Net Cash Used in Financing Activities
17
18
NET DECREASE IN CASH AND CASH EQUIVALENTS
Effect of Foreign Exchange on Cash and Cash Equivalents at the End of the Period
2016
(9 Months)
Rp
2015
(9 Months)
Rp
3,651,665,627,139
(2,664,749,824,683)
(637,843,105,673)
349,072,696,783
(4,980,296,491)
(43,447,773,375)
300,644,626,917
2,877,926,235,817
(2,116,830,299,640)
(521,588,602,221)
239,507,333,956
(9,710,189,545)
(17,166,734,547)
212,630,409,864
(44,246,839,040)
(73,541,773,128)
364,234,430
(292,145,067,430)
(2,680,555,548)
(338,708,227,588)
34,084,005
(217,957,674,968)
-(291,465,364,091)
(2,691,021,410)
(9,795,916,769)
(3,579,226,296)
-(16,066,164,475)
(3,500,000,000)
(10,211,400,681)
-(6,011,720,008)
(19,723,120,689)
(54,129,765,147)
(98,558,074,916)
329,236,820
(1,342,032,852)
CASH AND CASH EQUIVALENTS AT BEGINNING PERIOD
3
159,848,063,872
279,958,770,048
CASH AND CASH EQUIVALENTS AT ENDING PERIOD
3
106,047,535,545
180,058,662,280
The accompanying notes form an integral part of these
Interim consolidated financial statements
Draft/25 Nopember 2016
5
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
1. General
1.a. The Company’s Establishment
PT Siloam International Hospitals Tbk. (“the Company”) was established under the name of PT
Sentralindo Wirasta on August 3, 1996 based on the Deed of Establishment No. 3, which was made in
the presence of Myra Yuwono, S.H., a notary in Sukabumi. The deed of establishment was approved
by the Minister of Justice of the Republic of Indonesia in his decree No. C2-8639.HT.01.01.TH.’96. dated
August 27, 1996 and was published in the State Gazette No. 97, Supplement No. 9518 on December 3,
1996.
The Company’s articles of association have been amended several times, and the latest was by Notarial
Deed No. 52 dated March 23, 2016, made in the presence of Sriwi Bawana Nawaksari, S.H., M.Kn., a
notary in Tangerang, to change the Company’s articles of association one of them is the Company’s
purpose and objective. The changes in articles of association was approved by the Minister of Law and
Human Rights of the Republic of Indonesia in his decree No. AHU-AH.01.03-0039805 dated April 11,
2016.
In accordance with Article 3 of the Company's articles of association, the Company's principal activity is
engage in healthcare provision, including setting up and managing hospitals, polyclinics, health facilities
and supporting infrastructure, and engaging in government healthcare programs.
The Company commenced commercial operations in 2010 after the restructuring of PT Lippo Karawaci
Tbk’s hospital units. The Company's principal activity is engage in healthcare provision, including setting
up and managing hospitals. The operation of hospital units of the Company and the subsidiaries (the
Group) are in several cities on the island of Sumatera, Java, Bali, Kalimantan, Sulawesi and Nusa
Tenggara.
The Company’s head office is located at Building of Faculty Medicine UPH, 32th. Floor. Jl. Boulevard
Jend. Sudirman No.15, Tangerang 15810, Banten - Indonesia. The parent entity of the Company is PT
Megapratama Karya Persada and the ultimate parent entity is PT Lippo Karawaci Tbk.
1.b. The Company’s Initial Public Offering
The Company’s initial public offering of 156,100,000 shares was declared effective by the Indonesian
Financial Services Authority in its letter No. S-260/D.04/2013 dated September 2, 2013, and was listed
in the Indonesian Stock Exchange on September 12, 2013.
1.c. The Group’s Structure
The Company has directly or indirectly more than 50% ownership in subsidiaries as follows:
Final Draft/November 24, 2016
6
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
Domicile
Main
Business
Direct
Ownership
Percentage
Indirect
Ownership
Percentage
Year
Starting
Operation
PT Aritasindo Permaisemesta
Jakarta
Trading,
Development,
Mining,
Agriculture,
Land Transpotation,
Printing and
Industry
99.99%
--
--
64,124,071
76,559,368
PT Perdana Kencana Mandiri
Jakarta
Industry,
Development,
Trading,
Land Transpotation,
Workshop,
Printing,
Agriculture,
Mining and
Services
99.75%
--
--
519,803,207
600,000
Tangerang
Development,
Trading
and Services
Healthcare
Trading,
Development,
Land Transportation,
and Services
99.99%
--
--
446,884,661
9,138,115
-99.99%
59.69%
--
---
961,248,650
101,895,978,125
932,687,770
119,221,333,904
Healthcare
Development
and Services
Healthcare and
Pharmacy
Trading,
Development,
Industry,
Mining,
Land Transportation,
Agriculture,
Printing,
Workshop and
Services except
Services of Legal
and Tax
-99.97%
79.84%
--
2002
--
101,881,819,612
78,357,259,109
119,214,480,391
80,468,088,384
--
83.00%
2008
78,356,125,591
80,465,849,866
99.98%
--
--
208,547,878,543
227,620,609,168
Healthcare
including
Hospital,
Clinic,
Health Centre,
Polyclinic and
Other related
Services
Healthcare
Trading,
Industry
and Services
--
79.71%
2007
169,371,985,039
188,450,190,279
99.99%
99.99%
---
2013
2013
1,018,115,487
1,402,502,121
2,611,998,278
3,469,450,033
PT Multiselaras Anugerah
PT Nusa Medika Perkasa
PT Siloam Graha Utama and Subsidiary
Jakarta
Jakarta
PT East Jakarta Medika
PT Guchi Kencana Emas and Subsidiary
Bekasi
Jakarta
PT Golden First Atlanta
PT Prawira Tata Semesta and Subsidiary
PT Balikpapan Damai Husada
Jambi
Jakarta
Balikpapan
PT Siloam Emergency Services
PT Medika Harapan Cemerlang Indonesia
Tangerang
Tangerang
PT Pancawarna Semesta and Subsidiary
Tangerang
Trading,
Development,
Printing
and Services
99.99%
--
--
64,360,037,857
67,236,534,472
Depok
Hospital services
Clinic and
Policlinic,
Medical
Treatment Clinic
and
Other related
Services
Trading,
Development,
Printing
and Services
Trading,
Development,
Printing
and Services
Trading,
Development,
Printing
and Services
--
80.00%
2006
33,818,143,091
36,679,652,912
99.90%
--
--
1,205,502,721
1,012,776,138
99.99%
--
--
594,553,333
594,998,333
99.99%
--
--
594,220,000
594,665,000
PT Diagram Healthcare Indonesia
PT Adamanisa Karya Sejahtera
Jakarta
PT Brenada Karya Bangsa
Tangerang
PT Harmoni Selaras Indah
Tangerang
Final Draft/November 24, 2016
7
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
PT Kusuma Primadana and Subsidiary
PT Adijaya Buana Sakti and Subsidiary
Domicile
Main
Business
Tangerang
Trading,
Development,
Printing and
Healthcare including
Services,
Clinic and
Policlinic,
Medical Treatment
Clinic and Other
related Services
Services,
Development,
Trading,
Workshop,
Land Transportation,
Printing
and Agriculture
Trading,
Development
and Services
Healthcare include
Hospital
Clinic and
Health Center,
Polyclinic and
Other Related
Service
Services,
Development,
Trading,
Workshop,
Land Transportation
Industry,
Printing
and Agriculture
Trading,
Development,
Printing
and Services
Trading,
Development,
Printing
and Services
Tangerang
PT Siloam Sumsel Kemitraan
Tangerang
PT RS Siloam Hospital Sumsel
(d/h PT Karyatama Indah Sentosa)
Palembang
PT Optimum Karya Persada
Jakarta
PT Rosela Indah Cipta
Tangerang
PT Sembada Karya Megah
Tangerang
PT Trijaya Makmur Bersama
Tangerang
PT Visindo Galaxi Jaya
Tangerang
PT Tunggal Pilar Perkasa and Subsidiary
Tangerang
PT Tirtasari Kencana
Serang
PT Gramari Prima Nusa
Medan
PT Krisolis Jaya Mandiri
Kupang
PT Kusuma Bhakti Anugerah
Ambon
Final Draft/November 24, 2016
Trading,
Development,
Printing
and Services
Trading,
Development,
Real Estate,
Industry,
Printing,
Agribusiness
Services
and Transport
Trading,
Development,
Printing and
Services
Healthcare Services
including Hospitals,
Clinic,
Health Center
and Other
Related Service
Direct
Ownership
Percentage
99.99%
Indirect
Ownership
Percentage
--
Year
Starting
Operation
--
--
80.00%
--
86,671,405,047
144,275,110,897
--
56.00%
--
8,000,678,670
7,991,123,670
--
70.00%
2012
86,669,876,099
145,272,691,949
99.90%
--
--
1,000,525,300
1,000,970,300
99.99%
--
--
594,220,000
594,665,000
99.99%
--
--
602,221,157
602,666,157
99.99%
--
--
594,220,000
594,665,000
99.99%
--
--
4,984,503,333
4,984,948,333
99.99%
--
--
1,320,272,761,336
1,104,842,861,746
--
99.99%
--
1,146,614,218
1,129,177,218
--
99.99%
2014
132,536,312,953
142,285,912,947
--
99.99%
2014
189,757,104,377
135,816,231,542
--
99.99%
--
7,185,911,032
7,186,262,922
Healthcare and
Hospitals
Healthcare Services
including Hospitals,
Clinic,
Health Center
and Other
Related Service
Healthcare Services
Hospitals Clinic,
Health Center,
and Other
Related Service
8
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
86,672,025,047
144,276,175,897
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
PT Agung Cipta Raya
PT Bina Cipta Semesta
PT Mega Buana Bhakti
PT Taruna Perkasa Megah
PT Tataka Bumi Karya
PT Tataka Karya Indah
PT Siloam Medika Cemerlang
PT Koridor Usaha Maju and Subsidiary
PT Medika Sarana Traliansia and Subsidiary
PT Trisaka Reksa Waluya
PT Buana Utama Sejati
PT Sentra Sejahtera Utama
PT Bumi Unggul Persada*)
PT Berlian Cahaya Indah
Final Draft/November 24, 2016
Domicile
Semarang
Main
Business
Healthcare Services
including Hospitals,
Clinic,
and Other
Related Service
Padang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Bangka
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Yogya
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Bogor
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
Bandung
including Hospitals,
Clinic, Health Center
and Other
Related Service
Tangerang
Trading, Development,
Real Estate, Industry, Printing,
Agribusiness and Services
Tangerang
Trading,
Development,
Printing,
Agribusiness,
Services
Badung, Bali
Hospital
Public
Services
Badung
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Sorong
Hospital Service
Clinic, Policlinic
and Treatment
Clinic
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Direct
Ownership
Percentage
--
Indirect
Ownership
Percentage
99.99%
Year
Starting
Operation
--
--
99.99%
--
998,453,474
998,898,474
--
99.99%
--
7,991,308,336
6,289,590,225
--
99.99%
--
108,622,860,704
96,121,791,102
--
99.99%
--
22,140,591,003
845,251,870
--
99.99%
--
853,775,252
825,433,327
--
99.99%
2013
14,539,528,553
12,240,837,850
--
99.99%
--
504,494,600,950
480,847,930,537
--
99.99%
2008
291,390,763,441
266,476,908,793
--
99.99%
2008
136,045,604,756
137,390,081,888
--
99.99%
--
23,372,794,731
23,370,843,650
--
99.99%
--
600,000,000
600,000,000
--
99.99%
--
644,452,981
641,265,124
--
99.99%
2014
77,234,430,162
138,001,094,698
9
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
965,780,000
964,225,000
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
Domicile
Main
Business
PT Rashal Siar Cakra Medika
Jakarta
PT Mulia Pratama Cemerlang
Tangerang
PT Medika Rescue International
d/h formerly PT Karya Pesona Cemerlang
PT Indah Kemilau Abadi
Tangerang
PT Persada Dunia Semesta
Tangerang
PT Inti Pratama Medika
Tangerang
PT Sentra Sehat Sejahtera
Tangerang
PT Genta Raya Internusa
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Trading and
Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Jember
PT Sembilan Raksa Dinamika
Jakarta
PT Saritama Mandiri Zamrud
Jakarta
PT Gempita Nusa Sejahtera
Jakarta
PT Aryamedika Teguh Tunggal
Jakarta
PT Lintas Buana Jaya*)
Nusa Tenggara
Timur
PT Bina Bahtera Sejati*)
Baubau
Final Draft/November 24, 2016
Direct
Ownership
Percentage
--
Indirect
Ownership
Percentage
99.99%
Year
Starting
Operation
2008
--
99.99%
--
39,865,743,567
3,679,309,300
--
99.99%
--
3,267,915,053
878,649,715
--
99.99%
--
2,495,803,040
657,128,900
--
99.99%
--
10,465,750,452
2,349,333,094
--
99.99%
--
610,877,342
600,363,000
--
99.99%
--
2,072,408,873
878,649,715
--
99.99%
--
612,945,508
600,388,000
--
99.99%
2016
147,357,646,767
54,795,114,119
--
99.99%
--
600,000,000
600,000,000
--
99.99%
--
600,000,000
600,000,000
--
99.99%
--
600,000,000
600,000,000
--
99.99%
2016
45,194,122,437
9,886,018,026
--
99.99%
2016
42,511,870,096
600,000,000
10
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
75,806,642,408
59,415,242,800
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Subsidiary
Domicile
Main
Business
PT Lintang Laksana Utama*)
Kota Lubuk
Linggau
PT Ciptakarya Tirta Cemerlang*)
Tangerang
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Healthcare Services
including Hospitals,
Clinic, Health Center
and Other
Related Service
Trading,
Development
Printing,
Service
PT Mahkota Buana Selaras
Tangerang
Total Assets
September 30, 2016 December 31, 2015
Rp
Rp
600,000,000
600,000,000
Direct
Ownership
Percentage
--
Indirect
Ownership
Percentage
99.99%
Year
Starting
Operation
--
--
99.99%
--
600,000,000
600,000,000
99.99%
--
--
35,695,009,846
37,690,051,627
*) Established on 2015
1.d. Board of Commissioners, Directors, Employees and Audit Committee
Based on Notarial Deed No. 52 dated March 23, 2016, made in the presence of Sriwi Bawana
Nawaksari, S.H., M.Kn., Notary in Tangerang, which has been accepted by the Ministry of
Law and Human Rights of the Republic of Indonesia through notification No. AHU-AH.01.030039805 dated April 11, 2016, based on Notarial Deed No. 9 dated June 12, 2015, made in
the presence of Nurlani Yusup, S.H., M.Kn., notary in Tangerang, which has been accepted
by the Ministry of Law and Human Rights of the Republic of Indonesia through notification No.
AHU-AH.01.03-0942314 dated June 17, 2015 and based on Notarial Deed No. 1 dated May
2, 2014, made in the presence of Nurlani Yusup, S.H., M.Kn., Notary in Jakarta, which has
been accepted by Ministry of Law and Human Rights of the Republic of Indonesia through
notification No. AHU-06412.40.22.2014 dated May 5, 2014, the composition of the Board of
Commisioners and Directors as of June 30, 2016, December 31, 2015, 2014 and 2013, are
as follows:
Board of Commissioners
President Commissioner
Commissioner
Independent Commissioner
Final Draft/November 24, 2016
September 30, 2016
December 31, 2015
Lee Heok Seng
Theo Leo Sambuaga
Jenny Kuistono
-Farid Harianto
Dr. Niel Byron Nielson
Jonathan Limbong Parapak
Ketut Budi Wijaya
Theo Leo Sambuaga
Jenny Kuistono
Lambock V. Nahattands
Farid Harianto
Dr. Niel Byron Nielson
Jonathan Limbong Parapak
11
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
September 30, 2016
Directors
President Director
Director
Romeo Fernandez Lledo *)
Grace Frelita Indradjaja
Andry
Kailas N. Raina
Anang Prayudi
Prof. George Matthew
Budi Raharjo Legowo
Norita Alex
Caroline Riady
December 31, 2015
Romeo Fernandez Lledo *)
Grace Frelita Indradjaja
Andry
Kailas N. Raina
Anang Prayudi
Prof. George Matthew
Richard Hendro Setiadi WP
---
*) Independent Director
The audit committee composition as of September 30, 2016 and December 31, 2015 are as follows:
Audit Committee
Chairman
: Farid Harianto
Members
: Lim Kwang Tak
: Siswanto Pramono
As of September 30, 2016 and December 31, 2015, the Company’s Corporate Secretary is Cindy
Riswantyo. Head of internal audit is Gunawan HP.
As of September 30, 2016 and December 31, 2015, the Group have 7,643 and 6,974 permanent
employees, respectively (unaudited).
2. Summary of Significant Accounting Policies
2.a. Compliance with the Financial Accounting Standards
The interim consolidated financial statements were prepared and presented in accordance with
Indonesian Financial Accounting Standards which include the Statement of Financial Accounting
Standards (PSAK) and Interpretation of Financial Accounting Standards (ISAK) issued by the Financial
Accounting Standard Board – Indonesian Institute of Accountant (DSAK – IAI), and regulations in the
Capital Market include Regulations of Financial Sevices Authority/Capital Market and Supervisory Board
and Financial Institution (OJK/Bapepam-LK) No. VIII.G.7 regarding guidelines for the presentation of
financial statements, decree of Chairman of Bapepam-LK No. KEP-347/BL/2012 regarding presentation
and disclosure of financial statements of the issuer or public company.
2.b. Basis of Measurement and Preparation of Interim Consolidated Financial Statements
The interim consolidated financial statements have been prepared and presented based on going
concern assumption and accrual basis of accounting, except for the consolidated statements of cash
flows. Basis of measurement in preparation of these interim consolidated financial statements is the
historical costs concept, except for certain accounts which have been prepared on the basis of other
measurements as described in their respective policies. Historical cost is generally based on the fair
value of the consideration given in exchange for assets.
The interim consolidated statements of cash flows are prepared using the direct method by classifying
cash flows into operating, investing and financing activities.
Final Draft/November 24, 2016
12
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
The presentation currency used in the preparation of the interim consolidated financial statements is
Indonesian Rupiah which is the functional currency of the Group. Each entity in the Group determines
its own functional currency and items included in the financial statements of each entity are measured
using that functional currency.
2.c. New and Revised Statements and Interpretation of Financial Accounting
Standards Effective in the Current Year
The following are revision, amendments and adjustments of standards and interpretation of standard
issued by DSAK - IAI and effectively applied for the year starting on or after January 1, 2016, are as
follows:
Amendments
SFAS No. 4: “Separate Financial Statements”
SFAS No.15: “Investment in Associates and Joint Arrangements”
SFAS No.16 ”Property and equipment about Clarification of Acceptable Methods of Depreciation and
Amortization”,
SFAS No.19 ”Intangible Asset about Clarification of Acceptable Methods of Depreciation and
Amortization”,
SFAS No. 24: “Employee Benefits”
SFAS No. 65: “Consolidation Financial Statements”
SFAS No. 66: “Joint Arrangements”
SFAS No. 67: “Disclosures of Interest in Other Entities”
Adjustments
SFAS No. 5: “Operating Segments”
SFAS No. 7: “Related Party Disclosures”
SFAS No. 13: “Investments Property”
SFAS No. 16: “Property and Equipment”
SFAS No. 19: “Intangible Assets”
SFAS No. 22: “Business Combination”
SFAS No. 25: “Accounting Policies, Changes in Accounting Estimates and Errors”
SFAS No. 53: “Share-based Payments”
SFAS No. 68: “Fair Value Measurement”
The following is the impact of the revision, amendments and adjustments in accounting standards that
are relevant and significant to the interim consolidated financial statements of the Group among others:
SFAS No. 5 (Adjustment 2015): “Operating Segments”
The impact of the adjustment of this standard include:
a. Additional disclosure requirements of establishing the criteria for the combine of the operating
segments and the brief description of the operating segments have been combined and the
assessed economic indicators in determining of the combined operating segments have similar
economic characteristics,
b. Organize disclosures of the reconciliation of the reportable total assets segments to the entity’s
assets only if the assets segment are regularly provided to the chief operating decision maker,
and
c. Changes previous terminology is "reportable segments of the entity" to "the entity’s reportable
segments "and "based on differences in products and services" to "based on products and
services".
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statements.
Final Draft/November 24, 2016
13
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
SFAS No. 7 (Adjustment 2015): “Related Party Disclosures”
The impact of adjustment of this standard include:
a. Addition of requirements related parties, An entity is related to the reporting entity if entity or
members of the same group which that entity is related to others, provide member of the key
management personnel of the reporting entity or of a parent of the reporting entity.
b. Requiring that a reporting entity disclose the payment of key management personnel services
provided by the entity management and clarifies that the reporting entity is not required to disclose
the compensation paid of the entity management to its employees or Director, and
c. Changing the terminology of "the effective date" to be "effective date and transitional
requirement".
The Group had adopted the adjustment standard and had completed the requested requirements.
SFAS No. 13 (Adjustment 2015): “Investments Property”
Adjustment to this standard emphasize the difference between investment property and owneroccupied property and emphasize the need for consideration on the determination of whether the
acquisition of the investment property is classified as an asset acquisition or a business combination
within the scope of SFAS No. 22.
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 15 (Amendment 2015): “Investment in Associates and Joint Arrangements”
Adjustment to this standard, add that an entity which is not an investment entity having an interest in
investment entity and joint venture that is investment entity, then when applying the equity method
can maintain the fair value measurement that applied by the investment entity an associate or joint
venture in subsidiary where the investment entity an associate or joint venture are concerned.
The adoption of the amendment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 16 (Adjustment 2015): “Property and equipment”
Adjustment of this standard, add an explanation that:
a. The reduction is expected to occur in the future on the selling price of goods produced using an
property and equipment indicates presumption of the technical or commercial obsolescence of
the assets, and
b. Depreciation method based on the income generated by activities that use an asset is not
appropriate.
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 19 (Adjustment 2015): “Intangible Assets”
The Impact of the adjustments of this standard includes:
a. Provide additional explanation that the reduction is expected to occur in the future on the selling
price of goods produced using an intangible asset indicates presumption of the technical or
commercial obsolescence of the assets,
b. There is a presumption that the use of methods of amortization based on the revenues generated
by activities using the intangible assets allegedly not appropriate because it reflects factors that
are not directly related to the use of economic benefits contained in the intangible assets,
c. Basic selection the amortization of intangible assets is if its reflect the pattern of the estimated
economic benefits of the asset, and
Final Draft/November 24, 2016
14
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
d. In circumstances where the dominant inherent barrier factor in an intangible asset is the
achievement of revenue threshold, then the revenue generated can be used as a proper basis
for amortization.
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 22 (Adjustment 2015): “Business Combination”
The adjustments of this standard is added the explanation that:
a. SFAS No. 22 is not applied in accounting for the forming of a joint arrangement in the financial
statements of joint arrangement it self,
b. The obligation to pay contingent consideration that meet the definition of financial instruments
classified as financial liabilities or as equity, and
c. The entire contingent consideration which is not an equity, both financial and non-financial are
measured at fair value at each reporting date, with the changes in fair value are recognized in
profit or loss.
The adoption of the adjustment standard had no material effect to the interim consolidated financial
statement.
SFAS No. 24 (Amendment 2015): “Employee Benefits”
The amendment to this standard specifies that attribution dues from workers or third parties depend
on whether the contribution rate is set based on the number of year of services. If the dues based on
the number of year services, then the dues attributable to the period of services using the same
method with attribution required. If the amount of contributions does not depend on the number of year
of services then the contribution is recognized as a reduction of the cost of services in the period when
the related services provided by workers.
The adoption of the amendment standard had no material effect to the interim consolidated financial
statements.
SFAS No. 25 (Adjustment 2015): “Accounting Policies, Changes in Accounting Estimates and Errors”
Change in SFAS No. 25 (Adjustment 2015), mainly to incorporate the changes of editorial in the
previous standard.
The adoption of the adjustment of the standard had no material effect to the interim consolidated
financial statements.
SFAS No. 65 “Consolidated Financial Statements”
This standard replaces all of the guidance on control and consolidation in SFAS No. 4 (Revised 2009)
and ISAK No.7. The basic principle that a consolidated entity presents a parent and its subsidiaries
as if they are a single economic entity remains unchanged, as do the consolidation procedures.
PSAK 65 introduces a single consolidation model that identifies control as the basis for consolidation
for all types of entities, where control is based on whether an investor has power over the investee,
exposure / rights to variable returns from its involvement with the investee and the ability to use its
power over the investee to affect the amount of the returns.
The new standard also includes guidance on participating and protective rights and on agent principal relationships.
The adoption of the SFAS No. 65 has no impact to the interim consolidated financial statements upon
Final Draft/November 24, 2016
15
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
initial adoption, as its scope of consolidation remains unchanged.
SFAS No. 66 “Joint Arrangements”
PSAK No. 66 has purpose to establish principles for financial reporting entity that have interests in
jointly controlled scheme ( ie joint arrangements ). This statement is applied by all entities that are
parties to the joint arrangement .
SFAS No. 67 “Disclosure of Interests in Other Entities”
SFAS No. 67 combines, enhances, and replaces the disclosure requirements for subsidiaries, joint
arrangements, associates, and unconsolidated structured entities. This standard requires the Group
to disclose information that enables users of financial statements to evaluate the nature of, and risks
associated with, its interests in other entities and the effects of those interests on Group’s
consolidated financial statements.
The application of this standard has resulted in more extensive disclosures in the Group’s interim
consolidated financial statements.
SFAS No. 68 “Fair Value Measurement”
SFAS No. 68 defines fair value, sets out a single framework for measuring fair value and requires
disclosures about fair value measurements. SFAS No.68 applies when other SAKs require or permit
fair value measurements.
The Group has completed the disclosures requirement as required under this standard.
2.d. Principles of Consolidation
The interim consolidated financial statements incorporate the financial statements of the Company and
subsidiaries as described in Note 1.c.
A subsidiary is an entity controlled by the Group, the Group is exposed, or has rights, to variable returns
from its involvement with the entity and has the ability to affect those returns through its current ability
to direct the entity’s relevant activities (power over the investee).
The existence and effect of substantive potential voting rights that the Group has the practical ability to
exercise (i.e., substantive rights) are considered when assessing whether the Group controls another
entity.
The Group’s of interim consolidated financial statements incorporate the business results, cash flows,
assets and liabilities of the Company and all of its directly and indirectly controlled subsidiaries.
Subsidiaries are consolidated from the effective date of acquisition, which is the date on which the Group
effectively obtains control of the acquired business, until that control ceases.
Parent company prepares interim consolidated financial statements applying uniform accounting
policies for like transactions and other events in similar circumstances. All intragroup transactions,
balances, income, expenses and cash flows are eliminated in full on consolidation to reflect the financial
position of a single business entity.
The Group attributed the profit and loss and each component of other comprehensive income to the
owners of the parent and non-controlling interest even though this results in the non-controlling interests
having a deficit balance. The Group presents non-controlling interest in equity in the interim consolidated
statement of financial position, separately from the equity owners of the parent.
Final Draft/November 24, 2016
16
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
Changes in the parent’s ownership interest in a subsidiary that do not result in loss of control are equity
transactions (i.e., transactions with owners in their capacity as owners). When the proportion of equity
held by non-controlling interest change, the Group adjusted the carrying amounts of the controlling
interest and non-controlling interest to reflect the changes in their relative interest in the subsidiaries.
Any difference between the amount by which the non-controlling interests are adjusted and the fair value
of the consideration paid or received is recognized directly in equity and attributed to the owners of the
parent.
If the Group loses control, the Group:
(a) Derecognizes the assets (including goodwill) and liabilities of the subsidiary at their carrying
amounts at the date when control is lost;
(b) Derecognizes the carrying amount of any non-controlling interests in the former subsidiary at the
date when control is lost (including any components of other comprehensive income attributable
to them);
(c) Recognizes the fair value of the consideration received, if any, from the transaction, event or
circumstances that resulted in the loss of control;
(d) Recognizes any investment retained in the former subsidiary at fair value at the date when control
is lost;
(e) Reclassifies to profit or loss, or transfer directly to retained earnings if required by other
Accounting Standards, the amount recognized in other comprehensive income in relation to the
subsidiary;
(f)
Recognizes any resulting difference as a gain or loss attributable to the parent.
2.e. Foreign Currency Transactions and Balances
In preparing interim financial statements, each of the entity within the Group records by using the
currency of the primary economic environment in which the entity operates (“the functional currency”).
The functional currency of the Company and all of the subsidiaries is Rupiah.
Transactions during the period in foreign currencies are recorded in Rupiah by applying to the foreign
currency amount the spot exchange rate between Rupiah and the foreign currency at the date of
transactions. At the end of reporting period, foreign currency monetary items are translated to Rupiah
using the closing rate, i.e., middle rate of Bank of Indonesia as of September 30, 2016 and December
31, 2015 are as follows:
September 30, 2016 December 31, 2015
Rp
Rp
12,998
13,795
14,579
15,069
9,522
9,751
9,912
10,064
1 Dolar Amerika Serikat (USD)
1 Euro (EUR)
1 Dolar Singapura (SGD)
1 Dolar Australia (AUD)
Gains and losses from foreign exchange differences arising from foreign currency transactions are
recoqnized in profit or loss.
2.f. Cash and Cash Equivalent
Cash and cash equivalents are cash on hand, cash in banks (demand deposits) and time deposits with
maturity periods of three months or less at the time of placement that are not used as collateral or are
not restricted.
2.g. Related Parties Transactions and Balances
A related party is a person or an entity that is related to the reporting entity:
Final Draft/November 24, 2016
17
Paraf:
These interim consolidated financial statements are originally issued in Indonesian language
PT SILOAM INTERNATIONAL HOSPITALS Tbk AND SUBSIDIARIES
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Continued)
As of September 30, 2016 (Unaudited) and December 31, 2015 (Audited) and For the 9 (Nine) Months Periods Ended
September 30, 2016 and 2015 (Unaudited)
(In Full Rupiah, Unless Otherwise Stated)
(a) A person or a close member of that person’s family is related to a reporting entity if that person:
(i) has control or joint control over the reporting entity;
(ii) has significant inf